£61.84

This is the most expensive it has ever been. Walk away.

£62 today · previous high £62 · all-time low £62

Springer Immunotherapy of Sarcoma

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical
Generating forecast…
£61.84 £61.83 £61.83 £61.83 £61.84 £61.84 £61.84 22 July 2026 08 August 2026 25 August 2026 11 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 22 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 69 days • 1 price levels

Days at Price
69 days 0 17 35 52 69 £62 Days at Price

Price Analysis

Most common price: £62 (69 days, 100.0%)

Price range: £62 - £62

Price levels: 1 different prices over 69 days

Description

This book describes recent progress in the development of immunotherapies for advanced sarcoma, paying special attention to the potential role of manipulations of the sarcoma tumor immune microenvironment in improving patient outcomes. Readers will find a thorough overview of the state of the art in tumor immunology and immunotherapy as they relate to sarcoma. Among the topics addressed are advances in vaccine therapy; cytokine therapies; natural killer cells; the development of adoptive T cell strategies; and the scope for use of checkpoint inhibitors in patients with sarcoma, mirroring the tremendous breakthroughs made in other malignancies. Detailed information is provided on laboratory and clinical research, with analysis of outcomes of recent trials and identification of key challenges. There is every reason to believe that more effective and less toxic therapies for metastatic sarcoma can be attained by deepening our understanding of cancer immunology and building on the advances in immunotherapy for other solid tumors. In this context, Immunotherapy of Sarcoma will be of high interest for all medical oncologists responsible for the treatment of sarcoma patients.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
10 December 2018
Listed Since
08 May 2018

Barcode

No barcode data available

Similar Products You Might Like

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
89% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£113.76 06 Aug 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
88% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.01 10 Aug 2026
Immunotherapy for Gastrointestinal Cancer
87% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.11 08 Aug 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
87% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£88.00 13 Aug 2026
Immunotherapy for Pediatric Malignancies
87% match

Immunotherapy for Pediatric Malignancies

Springer

£113.90 08 Aug 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
86% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.01 06 Aug 2026
Pediatric Bone and Soft Tissue Sarcomas (Pediatric Oncology)
85% match

Pediatric Bone and Soft Tissue Sarcomas (Pediatric Oncology)

Springer

£103.27 08 Aug 2026
Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)
85% match

Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)

Springer

£101.65 30 Aug 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
85% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 06 Aug 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
85% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£149.86 04 Aug 2026
Battaglia contro il cancro con l'immunoterapia: Approcci innovativi per il successo
85% match

Battaglia contro il cancro con l'immunoterapia: Approcci innovativi per il successo

£74.00 15 Sep 2026
Innate and Adaptive Immunity in the Tumor Microenvironment: 1
84% match

Innate and Adaptive Immunity in the Tumor Microenvironment: 1

Springer

£76.42 13 Aug 2026
Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)
84% match

Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)

Springer

£74.67 29 Aug 2026
NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)
84% match

NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Elsevier

£119.39 05 Aug 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
83% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£76.42 06 Aug 2026
Contemporary Research on Renal Cell Carcinoma: Basic and Clinical Developments
83% match

Contemporary Research on Renal Cell Carcinoma: Basic and Clinical Developments

Springer

£76.42 15 Sep 2026
Orthopaedic Oncology: Primary and Metastatic Tumors of the Skeletal System: 162 (Cancer Treatment and Research, 162)
83% match

Orthopaedic Oncology: Primary and Metastatic Tumors of the Skeletal System: 162 (Cancer Treatment and Research, 162)

Springer

£94.74 15 Sep 2026
Orthopaedic Oncology: Primary and Metastatic Tumors of the Skeletal System: 162 (Cancer Treatment and Research, 162)
83% match

Orthopaedic Oncology: Primary and Metastatic Tumors of the Skeletal System: 162 (Cancer Treatment and Research, 162)

Springer

£73.14 04 Aug 2026
Symposium in Immunology VI: Tumor Immunology
83% match

Symposium in Immunology VI: Tumor Immunology

Springer

£74.78 28 Sep 2026
Immuno-Oncology: From Bench to Bedside
83% match

Immuno-Oncology: From Bench to Bedside

CREATESPACE

£82.80 13 Aug 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
83% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£149.64 05 Aug 2026
Soft Tissue Sarcomas: 15 (Cancer Treatment and Research)
83% match

Soft Tissue Sarcomas: 15 (Cancer Treatment and Research)

Springer

£85.62 15 Sep 2026
Malignant Mesothelioma and Pseudomyxoma
83% match

Malignant Mesothelioma and Pseudomyxoma

Springer

£76.42 15 Sep 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
83% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£108.01 13 Aug 2026